Idiopathic thrombocytopenic purpura (patient information): Difference between revisions

Jump to navigation Jump to search
m (Robot: Changing Category:Disease state to Category:Disease)
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 80: Line 80:
http://www.nlm.nih.gov/medlineplus/ency/article/000535.htm
http://www.nlm.nih.gov/medlineplus/ency/article/000535.htm


{{SIB}}
 
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 16:17, 9 August 2012

For the WikiDoc page for this topic, click here

Idiopathic thrombocytopenic purpura (patient information)
ICD-10 D69.3
ICD-9 287.31
OMIM 188030
DiseasesDB 6673
MedlinePlus 000535
MeSH D016553

WikiDoc Resources for Idiopathic thrombocytopenic purpura (patient information)

Articles

Most recent articles on Idiopathic thrombocytopenic purpura (patient information)

Most cited articles on Idiopathic thrombocytopenic purpura (patient information)

Review articles on Idiopathic thrombocytopenic purpura (patient information)

Articles on Idiopathic thrombocytopenic purpura (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Idiopathic thrombocytopenic purpura (patient information)

Images of Idiopathic thrombocytopenic purpura (patient information)

Photos of Idiopathic thrombocytopenic purpura (patient information)

Podcasts & MP3s on Idiopathic thrombocytopenic purpura (patient information)

Videos on Idiopathic thrombocytopenic purpura (patient information)

Evidence Based Medicine

Cochrane Collaboration on Idiopathic thrombocytopenic purpura (patient information)

Bandolier on Idiopathic thrombocytopenic purpura (patient information)

TRIP on Idiopathic thrombocytopenic purpura (patient information)

Clinical Trials

Ongoing Trials on Idiopathic thrombocytopenic purpura (patient information) at Clinical Trials.gov

Trial results on Idiopathic thrombocytopenic purpura (patient information)

Clinical Trials on Idiopathic thrombocytopenic purpura (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Idiopathic thrombocytopenic purpura (patient information)

NICE Guidance on Idiopathic thrombocytopenic purpura (patient information)

NHS PRODIGY Guidance

FDA on Idiopathic thrombocytopenic purpura (patient information)

CDC on Idiopathic thrombocytopenic purpura (patient information)

Books

Books on Idiopathic thrombocytopenic purpura (patient information)

News

Idiopathic thrombocytopenic purpura (patient information) in the news

Be alerted to news on Idiopathic thrombocytopenic purpura (patient information)

News trends on Idiopathic thrombocytopenic purpura (patient information)

Commentary

Blogs on Idiopathic thrombocytopenic purpura (patient information)

Definitions

Definitions of Idiopathic thrombocytopenic purpura (patient information)

Patient Resources / Community

Patient resources on Idiopathic thrombocytopenic purpura (patient information)

Discussion groups on Idiopathic thrombocytopenic purpura (patient information)

Patient Handouts on Idiopathic thrombocytopenic purpura (patient information)

Directions to Hospitals Treating Idiopathic thrombocytopenic purpura (patient information)

Risk calculators and risk factors for Idiopathic thrombocytopenic purpura (patient information)

Healthcare Provider Resources

Symptoms of Idiopathic thrombocytopenic purpura (patient information)

Causes & Risk Factors for Idiopathic thrombocytopenic purpura (patient information)

Diagnostic studies for Idiopathic thrombocytopenic purpura (patient information)

Treatment of Idiopathic thrombocytopenic purpura (patient information)

Continuing Medical Education (CME)

CME Programs on Idiopathic thrombocytopenic purpura (patient information)

International

Idiopathic thrombocytopenic purpura (patient information) en Espanol

Idiopathic thrombocytopenic purpura (patient information) en Francais

Business

Idiopathic thrombocytopenic purpura (patient information) in the Marketplace

Patents on Idiopathic thrombocytopenic purpura (patient information)

Experimental / Informatics

List of terms related to Idiopathic thrombocytopenic purpura (patient information)

Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Associate Editor-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.

Overview

Idiopathic thrombocytopenic purpura is a bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting. Persons with the disease have too few platelets in the blood.

ITP is sometimes called immune thrombocytopenic purpura.

What are the symptoms of Idiopathic thrombocytopenic purpura?

  • Abnormally heavy menstruation
  • Bleeding into the skin causes a characteristic skin rash that looks like pinpoint red spots (petechial rash)
  • Easy bruising
  • Nosebleed or bleeding in the mouth

What causes Idiopathic thrombocytopenic purpura?

  • ITP occurs when certain immune system cells produce antibodies against platelets. Platelets help your blood clot by clumping together to plug small holes in damaged blood vessels.
  • The antibodies attach to the platelets. The spleen destroys the platelets that carry the antibodies.
  • In children, the disease sometimes follows a viral infection. In adults, it is more often a chronic (long-term) disease and can occur after a viral infection, with use of certain drugs, during pregnancy, or as part of an immune disorder.
  • ITP affects women more frequently than men, and is more common in children than adults. The disease affects boys and girls equally.

When to seek urgent medical care?

Go to the emergency room or call the local emergency number (such as 911) if severe bleeding occurs, or if other new symptoms develop.

Diagnosis

  • Laboratory tests will be done to see how well your blood clots and to check your platelet count.
  • A complete blood count (CBC) shows a low number of platelets.
  • Blood clotting tests (PTT and PT) are normal.
  • Bleeding time is prolonged.
  • Platelet associated antibodies may be detected.
  • A bone marrow aspiration or biopsy appears normal or may show a greater than normal number of cells called megakaryocytes. These cells are an early form of platelets.

Treatment options

  • In children, the disease usually goes away without treatment. Some children, however, may need treatment.
  • Adults are usually started on an anti-inflammatory steroid medicine called prednisone. In some cases, surgery to remove the spleen (splenectomy) is recommended. This will increase the platelet count in about half of all patients. However, other drug treatments are usually recommended instead.
  • If the disease does not get better with prednisone, other treatments may include:
  • A medicine called danazol (Danocrine) taken by mouth
  • Injections of high-dose gamma globulin (an immune factor)
  • Drugs that suppress the immune system
  • Filtering antibodies out of the blood stream
  • Anti-RhD therapy for people with certain blood types
  • People with ITP should not take aspirin, ibuprofen, or warfarin because these drugs interfere with platelet function or blood clotting, and bleeding may occur.

Where to find medical care for Idiopathic thrombocytopenic purpura?

Directions to Hospitals Treating Idiopathic thrombocytopenic purpura

Prevention

The causes and risk factors are unknown, except in children when it may be related to a viral infection. Prevention methods are unknown.

What to expect (Outlook/Prognosis)?

With treatment, the chance of remission (a symptom-free period) is good. Rarely, ITP may become a long-term condition in adults and reappear, even after a symptom-free period.

Possible complications

Sudden and severe loss of blood from the digestive tract may occur. Bleeding into the brain may also occur.

Source

http://www.nlm.nih.gov/medlineplus/ency/article/000535.htm


Template:WH Template:WS